Kurtz Ronald M MD
Chief Medical Officer
Kurtz Ronald M MD has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Sep 3, 2026.
On the most recent filing, Kurtz Ronald M MD is listed as Chief Medical Officer at RxSight, Inc. Inside the rolling window, Kurtz Ronald M MD reported no open-market purchases and 1 open-market sale totaling $35K in RXST.
Companies traded
Other insiders at RXST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$35K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Kurtz Ronald M MD made?
Kurtz Ronald M MD has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Kurtz Ronald M MD trade?
Kurtz Ronald M MD has filed SEC Form 4 disclosures for 1 company, including RXST.
When was Kurtz Ronald M MD's most recent SEC Form 4 filing?
Kurtz Ronald M MD's most recent SEC Form 4 filing on Tracefour is dated Sep 3, 2026.
What is Kurtz Ronald M MD's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Kurtz Ronald M MD is listed as Chief Medical Officer.
What is Kurtz Ronald M MD's total buy and sell value in the current window?
Inside the rolling retention window, Kurtz Ronald M MD bought $0 and sold $35K based on SEC Form 4 filings.
What was Kurtz Ronald M MD's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 5,100 RXST shares on 2026-09-02, worth $35K, per SEC Form 4 filings.